Melbourne researchers have uncovered genes responsible for the way the body fights infection at the point of ‘invasion’ – whether it’s the skin, liver, lungs or the gut.
Research led by Dr Axel Kallies and Dr Klaas van Gisbergen at the Walter and Eliza Hall Institute of Medical Research, and Dr Laura Mackay from the University of Melbourne at the Peter Doherty Institute for Infection and Immunity has identified the genes Hobit and Blimp1 and found that they control a universal molecular program responsible for placing immune cells at the ‘front lines’ of the body to fight infection and cancer.
The presence of these organ-residing cells, which differ strikingly from their counterparts circulating in the blood stream, is key to local protection against viruses and bacteria.
Walter and Eliza Hall Institute’s Dr Kallies said the human body was fighting disease-causing pathogens every minute of its life. Dr Kallies said identifying how immune cells remain in the part of the body where they are needed most was critical to developing better ways to protect us from infections such as malaria or HIV.
“Discovering these ‘local heroes’ and knowing how the localised immune response is established allows us to find ways to ensure the required cells are positioned where they are needed most,” Dr Kallies said.
“This research will help us understand how immune cells adapt, survive and respond within the organs they protect. This is critical to rid the body of pathogens even before they are established and may also have implications for understanding how the spread of cancer could be prevented.”
The Doherty Institute’s Dr Laura Mackay, who is also an associate investigator with the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, said the factors that control the ‘tissue-residency’ of immune cells – their ability to locally reside in different organs of the body – was previously unknown.
“These results have major implications for developing strategies to induce immune cells in tissues that protect against infectious diseases,” Dr Mackay said.
“It’s a crucial discovery for future vaccine strategies – Hobit and Blimp1 would be key to placing immune cells in the tissues, which we know are really important for protection.”
The Latest on: Localised immune response
[google_news title=”” keyword=”Localised immune response” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Localised immune response
- Avenge Bio to Present at the Piper Sandler 34th Annual Healthcare Conferenceon November 17, 2022 at 11:09 am
Avenge Bio, Inc. ("Avenge") is an oncology-focused biotechnology company developing transformative cell-based immunotherapeutic products for the treatment of intractable solid tumors by incorporating ...
- Old mice regain leg strength after antibody treatmenton November 17, 2022 at 6:31 am
"This finding was unexpected because we primarily think of CD47 as an immune regulator ... muscle stem cells in response to aging and injury. Potential treatment to rebuild muscle "Anti-thrombospondin ...
- Machine learning can help predict patient response to cancer immunotherapyon November 17, 2022 at 4:59 am
"DeepTCR's predictive power is exciting," says John-William Sidhom, first author of the study, "but what I found more fascinating is that we were able to view what the model learned about the immune ...
- OncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanomaon November 15, 2022 at 2:44 pm
By the time of data cutoff, 10 of 12 patients had completed the neoadjuvant phase of up to three 4-week cycles of TAVO™-EP on days 1 and 8 (with an optional third treatment on day 15) concurrently ...
- How researchers used CRISPR gene editing to send immune cells after canceron November 15, 2022 at 11:51 am
And, even once tumors become established, there's often an immune response to the cancer. It's just that cancer cells evolve the ability to evade and/or tamp down the immune response, allowing ...
- Moderna says new Covid booster better against omicron BA.5, triggers immune response against BQ.1.1on November 14, 2022 at 4:13 pm
5 in people without prior infections. Moderna said it also found the new booster triggered robust immune response against omicron BQ.1.1, an emerging Covid subvariant in the U.S. In this article ...
- COVID-19 mRNA boosters induce robust but non-durable immune response in the elderlyon November 14, 2022 at 4:00 pm
Please use one of the following formats to cite this article in your essay, paper or report: APA Dutta, Sanchari Sinha. (2022, November 15). COVID-19 mRNA boosters induce robust but non-durable ...
- Moderna’s Omicron vaccine shows better immune response than COVID shotson November 14, 2022 at 2:35 pm
Moderna Inc said on Monday its Omicron-tailored vaccines produced a better immune response against the BA.4/5 subvariants in a mid-to-late stage study, when given as a booster dose, compared with ...
- Moderna Says New Covid Booster Strengthens Immune Response Against Subvariantson November 14, 2022 at 1:47 pm
By Sharon LaFraniere WASHINGTON — A new study by Moderna suggests that its updated coronavirus booster strengthens a key component of the immune system’s defense against the Omicron subvariant ...
- Inflammation: Immune system science explains why the body attacks itselfon November 13, 2022 at 2:06 pm
While inflammation is commonly associated with the pain of an injury or the many diseases it can cause, it is an important part of the normal immune response. The problems arise when this normally ...
via Bing News